| 1 |
Wang D, Yin L, Chen R, Tan W, Liang L, Xiang J, Zhang H, Zhou X, Deng H, Guo B, Wang Y. Senescent renal tubular epithelial cells activate fibroblasts by secreting Shh to promote the progression of diabetic kidney disease. Front Med (Lausanne) 2022;9:1018298. [PMID: 36760880 DOI: 10.3389/fmed.2022.1018298] [Reference Citation Analysis]
|
| 2 |
Huang Y, Wang S, Ke A, Guo K. Ferroptosis and its interaction with tumor immune microenvironment in liver cancer. Biochim Biophys Acta Rev Cancer 2023;1878:188848. [PMID: 36502929 DOI: 10.1016/j.bbcan.2022.188848] [Reference Citation Analysis]
|
| 3 |
Yao P, Liu Y. Terpenoids: Natural Compounds for Non-Alcoholic Fatty Liver Disease (NAFLD) Therapy. Molecules 2022;28. [PMID: 36615471 DOI: 10.3390/molecules28010272] [Reference Citation Analysis]
|
| 4 |
Jia FJ, Han J. Liver injury in COVID-19: Holds ferritinophagy-mediated ferroptosis accountable. World J Clin Cases 2022; 10(36): 13148-13156 [DOI: 10.12998/wjcc.v10.i36.13148] [Reference Citation Analysis]
|
| 5 |
Sun K, Li C, Liao S, Yao X, Ouyang Y, Liu Y, Wang Z, Li Z, Yao F. Ferritinophagy, a form of autophagic ferroptosis: New insights into cancer treatment. Front Pharmacol 2022;13:1043344. [DOI: 10.3389/fphar.2022.1043344] [Reference Citation Analysis]
|
| 6 |
Wang J, Zhu Q, Li R, Zhang J, Ye X, Li X. YAP1 protects against septic liver injury via ferroptosis resistance. Cell Biosci 2022;12:163. [PMID: 36182901 DOI: 10.1186/s13578-022-00902-7] [Reference Citation Analysis]
|
| 7 |
Ma C, Han L, Zhu Z, Heng Pang C, Pan G. Mineral metabolism and ferroptosis in non-alcoholic fatty liver diseases. Biochem Pharmacol 2022;205:115242. [PMID: 36084708 DOI: 10.1016/j.bcp.2022.115242] [Reference Citation Analysis]
|
| 8 |
Zhang J, Zheng Y, Wang Y, Wang J, Sang A, Song X, Li X. YAP1 alleviates sepsis-induced acute lung injury via inhibiting ferritinophagy-mediated ferroptosis. Front Immunol 2022;13:884362. [DOI: 10.3389/fimmu.2022.884362] [Reference Citation Analysis]
|
| 9 |
Pedroza-diaz J, Arroyave-ospina JC, Serna Salas S, Moshage H. Modulation of Oxidative Stress-Induced Senescence during Non-Alcoholic Fatty Liver Disease. Antioxidants 2022;11:975. [DOI: 10.3390/antiox11050975] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Gao Z, Dai L, Zhang H, Cheng L. Screening Potential Drugs for the Development of NAFLD Based on Drug Perturbation Gene Set. Computational and Mathematical Methods in Medicine 2022;2022:1-9. [DOI: 10.1155/2022/7606716] [Reference Citation Analysis]
|
